Notably, FAP exhibits minimal expression in normal tissues but is highly abundant in the stroma of over 90% of malignant epithelial tumors, making it a promising target for both pan‐cancer therapy and tumor imaging [278, 279]. This evidence concerns the gene FAP and cancer.